Kwang-Soo Kim is Professor and Director of the molecular neurobiology laboratory at McLean Hospital/Harvard Medical School. Based on his >30 years’ experiences to investigate the transcriptional regulatory cascade of midbrain dopamine neuronal system, he has been focusing on translating his research to novel therapeutic development of Parkinson’s disease (PD). In particular, since the loss of a specific cell type, (i.e., A9 dopamine neuron in the substantia nigra) directly causes the major motor symptoms of PD, his team is focused on human pluripotent stem cell (hiPSC) research and hiPSC-based personalized cell therapy. Toward this long-term goal, he is working on establishing an efficient platform to establish the safety and efficacy of hiPSC-based cell therapy for PD.
Kwang-Soo Kim, PhD
Director, Molecular Neurobiology Laboratory, McLean
Professor of Neuroscience and Psychiatry, HMS